Related Experiment Video
Updated: Aug 19, 2026
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Clinical features and visual outcome of intermediate uveitis in children
Rajni Jain1, Paulo Ferrante, Gopi T Reddy
1Uveitis Clinic, Moorfields Eye Hospital, London, UK.
Insights
Idiopathic intermediate uveitis in children is uncommon but can impact vision. Careful, tailored treatment can preserve sight in at least one eye.
Area of Science:
- Ophthalmology
- Pediatric Ophthalmology
- Uveitis Research
Background:
- Idiopathic intermediate uveitis (IIU) is a rare ocular inflammatory condition in children.
- Understanding its presentation, course, and treatment is crucial for pediatric eye care.
Purpose of the Study:
- To determine the clinical presentation, disease course, treatment strategies, and visual outcomes of IIU in pediatric patients.
- To analyze a cohort of children diagnosed with IIU, excluding those with systemic diseases.
Main Methods:
- Retrospective review of medical records for patients under 16 diagnosed with IIU between 1990 and 2001.
- Analysis of presenting symptoms, ocular signs (vitritis, snowbanks, cystoid macular edema), visual acuity changes, and treatment interventions.
- Exclusion of all patients with identified systemic diseases.
Main Results:
- Twenty-six pediatric patients (45 eyes) with IIU were identified.
- Common findings included vitritis, snowbanks (28 eyes), and cystoid macular edema (5 eyes).
- Treatment varied from no intervention to topical, localized, or systemic corticosteroids and cyclosporine, with 6 patients achieving good visual acuity (≥6/9).
Conclusions:
- IIU is uncommon in children but poses a significant risk to vision.
- Individually tailored immunosuppressive regimens are essential for managing disease severity and preserving vision.
- This study provides insights into the management of a substantial series of pediatric IIU cases.
Purpose:
To determine the presentation, course, treatment and outcome of idiopathic intermediate uveitis in children.
Methods:
The records of all patients under the age of 16 presenting with idiopathic intermediate uveitis under the care of one consultant (SL) between 1990 and 2001 were reviewed. The case notes were analysed with respect to presenting symptoms, associated conditions, ocular signs, change in visual acuity, treatment and complications. All patients with systemic disease were specifically excluded from the study.
Results:
Twenty-six patients (45 eyes) were identified with intermediate uveitis from 114 cases of childhood uveitis seen. The mean age at presentation was 10 years (range 7-13 years) and the average follow-up time was 3 years (range 0-7 years). All patients had varying degrees of vitritis, 28 eyes had snowbanks and 5 had cystoid macular oedema at presentation. Six patients required no treatment, five received topical treatment only, five were managed with orbital floor steroids alone and a further two were managed with orbital floor steroids and oral prednisolone. Systemic steroids were required in eight patients, four of whom also required cyclosporin. Six of these children had successful disease control and maintained a visual acuity of 6/9 in at least one affected eye.
Conclusion:
Idiopathic intermediate uveitis is a relatively uncommon condition in children but can have severe effects on vision. With careful management, vision can be preserved in at least one eye. This study describes the course of the disease in a relatively large series. The variation in disease severity prompts the use of individually tailored immunosuppressive regimens.
